https://www.hemlibra.com/
HEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment
Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety...
hemophilia aemicizumabtreatment
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-emicizumab-kxwh-hemophilia-or-without-factor-viii-inhibitors
FDA approves emicizumab-kxwh for hemophilia A with or without factor VIII inhibitors | FDA
On October 4, 2018, the Food and Drug Administration approved emicizumab-kxwh injection (HEMLIBRA, Genentech, Inc.) for prophylaxis to prevent or reduce the...
https://www.hemlibra-hcp.com/
Hemophilia A Treatment For Your Patients | HEMLIBRA® (emicizumab-kxwh)
Discover FDA approved HEMLIBRA® (emicizumab-kxwh) for prophylactic treatment in hemophilia A patients with or without factor VIII inhibitors. See BOXED WARNING.
for your patientshemophiliatreatmentemicizumab